SOURCE: eLocity Inc.

March 08, 2006 07:10 ET

Wednesday, March 8th Stock Trading Alert

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by eLocity Inc.

SARASOTA, FL -- (MARKET WIRE) -- March 8, 2006 -- eLocity's stocks to watch for today are -- Synova Healthcare Group. (OTC BB: SNVH), Martek Biosciences Corp. (NASDAQ: MATK), PDL BioPharma, Inc. (NASDAQ: PDLI), AVI BioPharma, Inc. (NASDAQ: AVII)

Investors, have a look at this company, Synova Healthcare Group. (OTC BB: SNVH). Through its two wholly owned subsidiaries, Synova Healthcare, Inc. and Synova Pre-Natal Healthcare, Inc., Synova Healthcare Group distributes rapid, non-invasive medical diagnostics to retail for over-the-counter use, and directly to health care providers for point of care use in the clinical setting. The company's products are designed to improve human health and quality of life by providing early and accurate awareness of the onset of certain medical conditions.

Tuesday, the company announced that its wholly owned subsidiary, Synova Healthcare, Inc., plans to launch a new, easy-to-use at-home test called Fem-V™, a non-invasive diagnostic test developed to assist women in diagnosing vaginal infections, and in determining the most appropriate treatment for these infections. Synova Healthcare said the product will be available later this spring in select pharmacies nationwide.

According to the company, a diagnosis by a qualified healthcare professional occurs in only 30% of cases, but the majority of women attempt to self-diagnose vaginal infections. Citing a Gallup survey completed by the National Vaginitis Association, the company found that 95% of women surveyed had heard of yeast infections, but that only 36% had actually heard of the more common vaginal infection called bacterial vaginosis (BV), which can lead to serious medical complications and health risks, including pelvic inflammatory disease (PID), and obstetric complications such as preterm labor and low birth weight babies. The company said that there is very little awareness among women concerning the appropriate diagnosis and treatment of these types of infections.

Synova assured that for the millions of American women who experience vaginal infections annually, this easy-to-use at-home test will assist in determining the most appropriate treatment. Test results will help determine if an over-the-counter treatment may be considered, or if they should seek treatment from a healthcare professional.

Synova Healthcare Group. (OTC BB: SNVH) is currently trading at around $2 a share.

Other stocks to watch:

Martek Biosciences Corp. (NASDAQ: MATK)

Martek Biosciences reported first quarter earnings Tuesday of $5.6 million, or $0.17 per diluted share, compared to $7.1 million, or $0.23 per diluted share, in the same quarter last year. Total revenues for the quarter were reported at $62.89 million, compared to $66.49 million in the same quarter last year.

MATK closed Tuesday's regular trading session at $30.53, but was trading 10% higher in the after hours market.

PDL BioPharma, Inc. (NASDAQ: PDLI)

Biopharmaceutical company PDL BioPharma announced Tuesday that the company has named Andrew Guggenhime, former CFO of Neoforma, Inc., as its chief financial officer effective April 3, 2006.

PDLI closed Tuesday's regular trading session at $30.92.

AVI BioPharma, Inc. (NASDAQ: AVII)

AVI BioPharma announced that the February issue of Nature Reviews Drug Discovery has highlighted the company's studies on the Ebola fever-causing Ebola virus. The company also announced that it has scheduled its earnings conference call for Wednesday, March 8, 2006.

AVII closed Tuesday's regular trading session at $6.92.

About eLocity Inc: eLocity owns and operates three financial websites for investors., Featuring active message boards for the penny stock trader, rumors and more., Visit this site for our daily top stock "GRID Makers." We rank stocks on volume, message board activity, sentiment and trend forecast., Bell2Bell features news stories, rumors, the InvestBoard and more.

Sign up for FREE at any of the sites above.

The newsletter is provided by eLocity Inc., an electronic broadcaster and publisher of this newsletter, is here after referred to as "the company." The company received compensation for this service for SNVH (Public Company). The compensation is forty thousand dollars from a non-affiliated third party, Investor Response LLC. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

The company reserves the right to trade in securities mentioned herein, and may make purchases or sales in such securities featured within our newsletter reports. The information contained in this publication is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. All statements of opinions, if any, (Our Summary) are those of the company.

The company relies exclusively on information gathered on the Public Company, such as public filings, press releases and its web sites. Investors should use the information contained in this publication as a starting point for conducting additional research on the Public Company in order to allow the investor to form his or her own opinion regarding the Public Company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.

Investing in the Public Company that this newsletter is providing service for should be reviewed is speculative and a high-risk and may result in the loss of some or all of any investment made in the client. This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended.

The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.

Contact Information

  • Contact:
    eLocity Inc.
    Thomas Clay